ArticlePharmaceutical statistics2022
CUSUMIN: A cumulative sum interval design for cancer phase I dose finding studies.
Tomoyoshi Hatayama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticlePharmaceutical statistics2022
Tomoyoshi Hatayama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.